 |
 |
News Search |
 |
 |
 |
Testosterone and Alzheimer's—a Possible Tau Connection
|
 |
 |
|
 |
 |
24 January 2002. More women than men have Alzheimer's disease (AD), suggesting
that loss of estrogen may increase the risk for AD in postmenopausal women.
Recent studies to demonstrate that estrogen protects Alzheimer's patients have
had mixed results. In the January 22 advanced online publication in PNAS, Sozos
Papasozomenos and Alikunju Shanavas at the University of Texas demonstrate that
testosterone may prove beneficial in preventing the disease.
The researchers used an animal model to test the effects of testosterone and
estradiol on heat shock induced phosphorylation of tau, the major component
of the neurofibrillary tangles that are associated with AD. They found that
testosterone, but not estradiol, could prevent phosphorylation of the microtubule-associated
protein, specifically at Ser404.
Extracts from the forebrains of heat-shocked rats were tested for activity
of glycogen synthase kinase-3β GSK-3β
, cyclin-dependent kinase 5 (Cdk5), and c-Jun N-terminal kinase (JNK), which
had previously been shown to be involved in tau phosphorylation. In the presence
of testosterone, only GSK-3β activity was affected,
being significantly reduced. Using phosphospecific antibodies, the authors showed
the androgen to prevent phosphorylation of Tyr216, which is required for full
activation of the kinase.
This work provides a molecular basis for previous observations that men with
lower plasma testosterone are more susceptible to developing Alzheimer's.-Tom Fagan.
Reference:
Papasozomenos SCh, Shanavas A. Testosterone prevents
the heat shock-induced overactivation of glycogen synthase kinase-3β
but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase
and concomitantly abolishes hyperphosphorylation of t:
Implications for Alzheimer's disease. PNAS advance online publication 22 January
2002. Abstract
See related news item
See Related NewScientist
News Article
|
 |
 |
 |
Comments on News and Primary Papers |
 |
  |
| |
Comment by: Samuel Gandy
|
 |
 |
Submitted 30 January 2002
| Permalink
|
Posted 30 January 2002
|
 |
 |
This research group uses hyperthermia to induce a form of generalized stress
that this group calls "heat shock" in its reports, but it is my understanding
that this group is alone in application of this nomenclature. Exposure of
cultured cells (not living animals) is a more accepted protocol for inducing
"heat shock" and studying "heat shock proteins", many of which act as chaperones,
as a means of defense against the protein denaturation caused by the elevated
temperature. Exposure of living animals to a heated environment is most typically
used to model the human febrile state (i.e., fever). Elevation of body temperature
has a myriad of effects, both systemic and neurological. In general, metabolism
is accelerated, at least within a limited range. At very supraphysiological
levels, proteins unfold and denature, and cells die.
This report exemplifies an important stage in the study of the molecular
pathology of tau, i.e., moving into live animal models. Rodent tau is not
identical to its human counterpart, and...
Read more
This research group uses hyperthermia to induce a form of generalized stress
that this group calls "heat shock" in its reports, but it is my understanding
that this group is alone in application of this nomenclature. Exposure of
cultured cells (not living animals) is a more accepted protocol for inducing
"heat shock" and studying "heat shock proteins", many of which act as chaperones,
as a means of defense against the protein denaturation caused by the elevated
temperature. Exposure of living animals to a heated environment is most typically
used to model the human febrile state (i.e., fever). Elevation of body temperature
has a myriad of effects, both systemic and neurological. In general, metabolism
is accelerated, at least within a limited range. At very supraphysiological
levels, proteins unfold and denature, and cells die.
This report exemplifies an important stage in the study of the molecular
pathology of tau, i.e., moving into live animal models. Rodent tau is not
identical to its human counterpart, and rodent tau is not competent to form
neurofibrillary tangles. Transgenic mice bearing human tau with the mutation
that causes familial frontotemporal dementia have recently been developed
by Mike Hutton and his colleagues at Mayo Jacksonville. The neurons in the
brains of these transgenic mice, when exposed to a well-documented insult
such as amyloid peptides, are now competent to assume a conformation highly
similar to neurofibrillary tangles (Lewis
et al. 2001, Gotz
et al. 2001). This rodent will now be a valuable tool for evaluating in
vivo the role in tangle formation for various protein kinases and phosphatases
as well as small molecules (e.g., glycosaminoglycans). In light of the rat
"heat shock" data, it would be very interesting to expose a tangle-competent
mouse to hyperthermia and assay to determine whether this insult modifies
the intensity or time course of tangle formation.
See
Related news item View all comments by Samuel Gandy
|
 |

|
| |
Comment by: Richard Bowen
|
 |
 |
Submitted 30 January 2002
| Permalink
|
Posted 30 January 2002
|
 |
 |
The authors bring up some interesting points and I concur that sex steroid hormones probably play a role, whether directly or indirectly, in the pathogenesis of AD. However, the authors' conclusions fail to consider at least two confounding factors. One might suspect that there is a gender difference in the expression of sex steroid hormone receptors, yet the experiment was only performed on female rats. It would be interesting to see what would occur if gonadectomized male rats were administered estrogen. It might well be that one would see the same results of administering testosterone to gonadectomized female rats.
In addition, the effect of alterations in gonadotropin secretion was not considered. Gonadotropins have been shown to upregulate CDK 5 in reproductive tissues (Musa FR 2000). Therefore, in vivo, any effects of the sex steroids might be partially mediated by alterations in gondadotropin secretion.
One other issue that may be of importance is that the experiment was performed during the peri-pubertal period. Future experiments should probably be delayed until...
Read more
The authors bring up some interesting points and I concur that sex steroid hormones probably play a role, whether directly or indirectly, in the pathogenesis of AD. However, the authors' conclusions fail to consider at least two confounding factors. One might suspect that there is a gender difference in the expression of sex steroid hormone receptors, yet the experiment was only performed on female rats. It would be interesting to see what would occur if gonadectomized male rats were administered estrogen. It might well be that one would see the same results of administering testosterone to gonadectomized female rats.
In addition, the effect of alterations in gonadotropin secretion was not considered. Gonadotropins have been shown to upregulate CDK 5 in reproductive tissues (Musa FR 2000). Therefore, in vivo, any effects of the sex steroids might be partially mediated by alterations in gondadotropin secretion.
One other issue that may be of importance is that the experiment was performed during the peri-pubertal period. Future experiments should probably be delayed until the rats have completed puberty. This is because sex steroid receptor expression might be developmentally regulated.
View all comments by Richard Bowen
|
 |
 |
 |
| |
Submit a Comment on this News Article |
 |
 |
 |
 |
|
|
|
 |